It can reduce the risk of a stroke, heart attack, or death in adults who have type 2 diabetes along with heart and blood vessel disease, according to Medline Plus
Some may cover the medication fully or partially, while others may require prior authorization or may not cover it at all
For example, a study by Falutz et al., New England Journal of Medicine (2010) demonstrated measurable reductions in VAT with Tesamorelin therapy, supporting its clinical efficacy
Eric Topol, MD GLP-1s seem are showing so much promise in a variety of diseases that it is exciting what such sparks of innovation that will be future developed from GLP-1 to mitigate some of our biggest healthcare challenges
With more generic pharmaceuticals hitting the market, the glucagon-like peptide 1 (GLP-1) agonists market is expected to develop in the region
Comparisons of baseline characteristics between groups were performed using independent-sample t tests or MannWhitney U tests for continuous variables and chi-square or Fishers exact tests for categorical variables